Karen Ling is Director of TherapeuticsMD, Inc.. Currently has a direct ownership of 4,591 shares of TXMD, which is worth approximately $6,106. The most recent transaction as insider was on Aug 18, 2022, when has been sold 1,984 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.59K
0% 3M change
0% 12M change
Total Value Held $6,106

Karen Ling Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
1,984 Added 30.17%
4,591 Common Stock
Aug 17 2021
BUY
Open market or private purchase
$25,084 $0.75 p/Share
33,445 Added 20.42%
130,309 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
-
96,864 Added 50.0%
96,864 Common Stock

Also insider at

AIG
AMERICAN INTERNATIONAL GROUP, INC. Financial Services
IRTC
iRhythm Technologies, Inc. Healthcare
MNKPF
Mallinckrodt plc Healthcare
BLCO
Bausch & Lomb Corp Healthcare
KL

Karen Ling

Director
Boca Raton, FL

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Track Activities on TXMD